Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-25 @ 2:38 AM
NCT ID:
NCT04269434
Eligibility Criteria:
Inclusion Criteria:
* Able and willing to provide informed consent
* Men (born as males) and transwomen aged 18 or more
* Has had sex\*\* with another man in the last 12 months
* Enrolled in Belgian PrEP program at ITM/HSP/EH/CHU/UZG with approval for TDF/FTC (Tenofovir disoproxil fumarate/Emtricitabine) reimbursement from a Belgian Medical Aid
* Willing to comply with the study procedures and to attend the clinic for the 3-monthly visits
Exclusion Criteria:
* Enrolment in another interventional trial
* Tests HIV-positive at screening
* Symptoms of proctitis or urethritis
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT04269434
Study Brief:
Protocol Section:
NCT04269434